Articles by Angie Drakulich - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Angie Drakulich

Angie Drakulich

Editorial Director, Pharmaceutical Technology

See Angie Drakulich's bio page.

A Look Ahead at Manufacturing and Regulation
January 2, 2013

FDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, and overall approaches.

A Look Ahead for 2013
January 2, 2013

From time to time, it's important to take stock of the industry from both a retrospective and prospective point of view.

A Look Ahead at Manufacturing and Regulation
January 1, 2013

FDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, overall approaches.

When Disaster Strikes at Home
December 2, 2012

PDA's strategic plan calls for maintaining valuable and effective relationships with global regulators.

Innovation in a Leading Disease Target: Alzheimer's
December 2, 2012

An interview with Eric M. Parker, Ph.D., Executive Director and Neuroscience Site Lead, Merck Research Laboratories, about the Merck BACE team's winning research.

Pharma Innovation
December 2, 2012

A look at the year's leaders in innovation strategy, including the top bio/pharmaceutical companies and award recipients from AAPS, PhRMA, and CPhI.

Knowledge is Power
November 2, 2012

Global tactics that incorporate online technologies and social media are reshaping disease response.

FDA Issues 483 to New England Compounding Center
October 29, 2012

New England Compounding Center gets 483 after linked fungal meningitis outbreak.

Grad Student Research Sparks Innovation through AAPS Awards
October 15, 2012

At this week's AAPS 2012 Annual Meeting in Chicago, graduate students across the country are being honored for their research and work in bio/pharmaceutical innovation. Pharmaceutical Technology had the chance to talk with a few of the recipients.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here